- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2012
- Public Summary Document (PSD) March 2012 PBAC Meeting - PDF
Pregabalin – March 2012
Pregabalin, capsules, 25 mg, 75 mg, 150 mg and 300 mg, Lyrica® - March 2012
Last updated
8 November 2023
